Mylan Can't Deduct $50M Legal Fees For FDA Approval, IRS Says
By David Hansen · December 3, 2018, 8:10 PM EST
The $50 million Mylan Inc. spent on patent litigation after applying for a license to sell a generic copy of a drug is not a tax-deductible business expense because it was...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login